Just In
- 48 min ago Summer Style: 6 Must-Try Colors To Stay Fashionably Cool Like B-Town Divas!
- 2 hrs ago Belgian Man Cleared Of Drunk Driving Because His Body Produces Alcohol Due To A Rare Condition
- 3 hrs ago Amitabh Bachchan's Youthful Avatar In Kalki 2898 AD Is Impressive, Check Actors Who Sported Digital De-Aging!
- 3 hrs ago Full Moon In Scorpio In April 2024: How It Will Affect 12 Zodiac Signs
Don't Miss
- Movies Bade Miyan Chote Miyan Box Office Day 14: Akshay’s Film Struggles To Touch 60Cr; To Record Its Lowest Number
- Sports Nitish Rana gets emotional while talking about his handicapped father driving Maruti 800 automatic
- News Dry Days In Kerala: Alcohol Sales Banned For 3 days As Liquor Shops, Bars Remain Closed - Timings & Details
- Travel Mumbai Opens BMC Headquarters For Exclusive Heritage Tour
- Automobiles The Rise and Fall of the TVS Jive: India's Pioneering Clutchless Motorcycle
- Education TS Inter Results 2024 Toppers' List, Check Out the Districts That Top the List
- Finance PayU Gets RBI's In-principle Nod To Operate As Payment Aggregator
- Technology Realme Narzo 70 5G, Narzo 70x 5G Launched in India: Check Price, Specs, Availability
Molnupiravir Not To Be Included In COVID-19 Clinical Management Protocol: ICMR
The Indian Council of Medical Research (ICMR)'s National Task Force for COVID-19 has decided against including antiviral drug Molnupiravir in the Clinical Management Protocol for COVID-19 as of now, official sources said on Tuesday.
The experts of the task force cited safety concerns and argued that Molnupiravir was not of much benefit in Covid treatment to arrive at the decision in a meeting held on Monday.
According to the Health Ministry, Molnupiravir is an antiviral drug that inhibits SARS-CoV-2 replication by viral mutagenesis. This anti-Covid pill got the Drug Regulator General of India's approval on December 28 for restricted use in emergencies.
"Members of the National Task Force for COVID-19 were not in favour of including the drug in the national treatment guidelines citing that it does not have much benefit in the treatment of coronavirus infection and that there were safety concerns," an official source told PTI.
Indian Council of Medical Research (ICMR) chief Dr Balram Bhargava had last week said that Molnupiravir has major safety concerns. He added that WHO and the UK have not included it for treatment.
"We have to remember that this drug has major safety concerns. It can cause teratogenicity, mutagenicity and cartilage damage. It can damage the muscles also.
"Contraception will have to be done for three months for male and female if this drug is given because the child born could be problematic due to teratogenic influence," he had said.
The UK Medicines and Healthcare products Regulatory Agency had on December 4 granted approval for Molnupiravir under special conditions for treatment of mild to moderate COVID-19 in adults who have at least one risk factor for developing severe illness.
USFDA on December 23 granted Emergency Use Authorisation for the drug for treating mild-to-moderate COVID-19 in adults at high risk for progression to severe disease, including hospitalization or death, and for whom alternative treatment options are not accessible or clinically appropriate.
According to conditions, the drug should be sold by retail only under the prescription of medical specialists and the recommended dose should be 800 mg twice daily for five days.
- wellnessPhase III Trials Of Covid Drug Movfor Show Positive Results, Says Hetero
- healthNew Antiviral Drug Combo Highly Effective Against COVID-19: Study
- healthCOVID Antiviral Drug Molnupiravir Has Major Safety Concerns: ICMR Chief Dr Balram Bhargava
- disorders cureCOVID Antiviral Oral Pill Molnupiravir: Know Price, Dosage, Side Effects And Other Details
- healthSun Pharma Gets DCGI Nod To Market Molnupiravir For COVID-19 Treatment
- healthPanel Recommends EUA For Covid-19 Vaccines Covovax, Corbevax And Anti-Covid Pill Molnupiravir
- pregnancy parentingMysterious Pneumonia Outbreak In China: What Are The Long-Term Effects Of Pneumonia In Children?
- healthCan You Get Back COVID-Related Loss Of Sense Of Smell And Taste (Parosmia)? Looks Like You Can!
- healthDid Covid-10 Vaccination Increase Risk Of Sudden Deaths In Young Adults? ICMR Finds This..
- wellnessDelhi Air Pollution, Air Quality Very Poor: Do Covid Masks Help Reduce Pollution Side Effects?
- healthNobel Prize 2023: Scientists Behind The COVID-19 mRNA Vaccines Wins
- healthWhat Is Disease X? 20 Times More Deadlier Than Covid 19; Can Cause 50 Million Deaths, Does It Have Vaccine?